IXICO Releases Beta Version of MyBrainBook®

May 26, 2015
News Download PDF

26 May 2015, IXICO plc (Ticker: IXI) (‘IXICO’ or the ‘Company’), the brain health company, today announces the release of a beta version of MyBrainBook®, its digital support platform for evaluation by people with dementia and their carers.  MyBrainBook® is being made available for free evaluation during the beta phase to those who would like to start using it and contributing to its ongoing evolution and improvement as a support tool at the leading edge of digital dementia care.


The goal of MyBrainBook® is to put people with dementia at the centre of decisions about their care, connecting them with family, health and social care support that can enable them to live independently for longer.  Further information including a video introducing MyBrainBook® is available at www.mybrainbook.com

The release coincides with Dementia Awareness week in the UK and the start of a nine-month pilot study with MindCare in Lewisham (part of Bromley and Lewisham Mind) which is engaging with people who have been diagnosed with dementia. 


Professor Derek Hill, Chief Executive of IXICO, commented:

“MyBrainBook® is at the heart of IXICO’s evolving digital healthcare platform and one of our key initiatives to improve the lives of people being diagnosed with dementia and their families.  From the outset we have been working with potential users to develop MyBrainBook® so that it is both relevant and user-friendly.”




Derek Hill, CEO

Susan Lowther, CFO

Charles Spicer, VP Corporate Development

+44 20 3763 7499

FTI Consulting Limited (Investor Relations)

Simon Conway

Mo Noonan

Matthew Moss

+44 20 3727 1000


Notes to Editors

About MyBrainBook®

MyBrainBook® has been developed by IXICO as a radical new way of providing the best care to people with dementia. MyBrainBook is a digital hub which gives people with dementia and their carers the ability to build a personal profile and action plan with information they provide about the important aspects of their life. Restricted access is available to healthcare workers to ensure the appropriate support can be provided when needed.

More information is available on www.mybrainbook.com.



IXICO, the brain health company, uses its innovative and proprietary digital health technologies to help those involved in researching and treating serious diseases to make rapid, informed decisions targeted at improving patient outcomes.   IXICO has significant experience working with global pharmaceutical and biotechnology companies supporting clinical studies in the field of neuro-degenerative disorders including Alzheimer’s disease, Huntington’s disease, other causes of dementia and Multiple Sclerosis. 

More information is available on www.ixico.com.